In recent years, Taiwan’s biotechnology and medical sectors have experienced significant growth, closely aligned with global scientific advancements. Research and development efforts continue to expand in advanced therapeutic modalities, including cell and gene therapies and nucleic acid–based medicines, collectively referred to as Advanced Therapy Medicinal Products (ATMPs). As these innovative therapies play a critical role…